Surgically positioned neutron flux activated high energy therapeutic charged particle generation system
A process for treating highly localized carcinoma cells that provides precise positioning of a therapeutic source of highly ionizing but weakly penetrating radiation, which can be shaped so that it irradiates essentially only the volume of the tumor. The intensity and duration of the radiation produced by the source can be activated and deactivated by controlling the neutron flux generated by an array of electrically controlled neutron generators positioned outside the body being treated. The energy of the neutrons that interact with the source element can be adjusted to optimize the reaction rate of the ionized radiation production by utilizing neutron moderating material between the neutron generator array and the body. The source device may be left in place and reactivated as needed to ensure the tumor is eradicated without exposing the patient to any additional radiation between treatments. The source device may be removed once treatment is completed.
1. A system, comprising:
a therapeutic source configured to treat localized carcinoma cells in a body of an animal, wherein the therapeutic source:
is non-toxic and insoluble in water;
is configurable between:
a first state, wherein the therapeutic source is substantially nonradioactive; and
a second state, wherein the therapeutic source is a source of highly ionizing but weakly penetrating radiation in the second state, wherein the therapeutic source is configured to transition to the second state based on the therapeutic source being exposed to a neutron field at or above a given activity;
comprises B 4 C enriched in B-10 content;
comprises a radiation shield material formed on a side thereof that shields at least some of the highly ionizing radiation, but is substantially transparent to neutrons; and
is in a shape in the order of a micron's thickness.
2. The system of claim 1 , further comprising a neutron generator configured to irradiate the therapeutic source, based on the therapeutic source being implanted in the body of the animal.
3. The system of claim 2 , wherein the neutron generator comprises a Neutristor.
4. The system of claim 2 , further comprises a neutron moderating material positionable between the neutron generator and the therapeutic source, wherein the neutron moderating material is configured to adjust the neutron energy to optimize the highly ionizing, but weakly penetrating radiation produced by the therapeutic source.
5. The system of claim 4 , wherein the neutron moderating material comprises D 2 O.
6. The system of claim 4 , wherein the neutron moderating material comprises C.
7. The system of claim 2 , further comprising a gamma spectrometer configured to monitor the intensity of gamma radiation emitted by a product of the neutron radiation of the therapeutic source.
8. The system of claim 7 , further comprising a control system configured to monitor the intensity of the gamma radiation and neutron activity of the neutron field to determine a radiation dose that has been applied to the body of the animal.
9. The system of claim 8 , wherein the control system is configured to control the intensity of the neutron field based on the monitored gamma intensity and the radiation dose.
10. A system, comprising:
a therapeutic source configured to treat localized carcinoma cells in a body of an animal, wherein the therapeutic source:
is non-toxic and insoluble in water;
is configurable between:
a first state, wherein the therapeutic source is substantially nonradioactive; and
a second state, wherein the therapeutic source is a source of highly ionizing but weakly penetrating radiation in the second state, wherein the therapeutic source is configured to transition to the second state based on the therapeutic source being exposed to a neutron field at or above a given activity;
comprises P-31;
comprises a radiation shield material formed on a side thereof that shields at least some of the highly ionizing radiation, but is substantially transparent to neutrons; and
is in a shape in the order of a micron's thickness.
11. The system of claim 10 , further comprising a neutron generator configured to irradiate the therapeutic source, based on the therapeutic source being implanted in the body of the animal.
12. The system of claim 11 , wherein the neutron generator comprises a Neutristor.
13. The system of claim 11 , further comprises a neutron moderating material positionable between the neutron generator and the therapeutic source, wherein the neutron moderating material is configured to adjust the neutron energy to optimize the highly ionizing, but weakly penetrating radiation produced by the therapeutic source.
14. The system of claim 13 , wherein the neutron moderating material comprises D 2 O or C.
15. The system of claim 11 , further comprising a gamma spectrometer configured to monitor the intensity of gamma radiation emitted by a product of the neutron radiation of the therapeutic source.
16. The system of claim 15 , further comprising a control system configured to monitor the intensity of the gamma radiation and neutron activity of the neutron field to determine a radiation dose that has been applied to the body of the animal.
17. The system of claim 16 , wherein the control system is configured to control the intensity of the neutron field based on the monitored gamma intensity and the radiation dose.
18. A method of treating localized carcinoma cells in a body of an animal, the method comprising:
implanting a therapeutic source in the body adjacent to the localized carcinoma cells, wherein the therapeutic source:
is non-toxic and insoluble in water;
is configurable between:
a first state, wherein the therapeutic source is substantially nonradioactive; and
a second state, wherein the therapeutic source is a source of highly ionizing but weakly penetrating radiation in the second state, wherein the therapeutic source is configured to transition to the second state based on the therapeutic source being exposed to a neutron field at or above a given activity;
comprises B 4 C enriched in B-10 content;
comprises a radiation shield material formed on a side thereof that shields at least some of the highly ionizing radiation, but is substantially transparent to neutrons; and
is in a shape in the order of a micron's thickness; and
irradiating the therapeutic source from outside the body with the neutron field at or above the given activity with a neutron generator.
19. The method of claim 18 , further comprising positioning a neutron moderating material between the neutron generator and the therapeutic source.
20. The method of claim 19 , further comprising:
monitoring the intensity of gamma radiation emitted by a product of the neutron radiation of the therapeutic source;
monitoring the neutron activity of the neutron field;
determining a radiation dose that has been applied to the body of the animal, based on the monitored neutron activity; and
controlling the intensity of the neutron field based on the monitored intensity and the determined radiation dose.